These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8797463)

  • 21. Safety of high-dose intravenous immunoglobulin in systemic autoimmune diseases.
    Tufan F; Kamali S; Erer B; Gul A; Inanc M; Ocal L; Konice M; Aral O
    Clin Rheumatol; 2007 Nov; 26(11):1913-5. PubMed ID: 17636363
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Severe antibody-mediated rejection following IVIG infusion in a kidney transplant recipient with BK-virus nephropathy.
    Mainra R; Xu Q; Chibbar R; Hassan A; Shoker A
    Transpl Immunol; 2013 Jun; 28(4):145-7. PubMed ID: 23685054
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence-based strategies to reduce intravenous immunoglobulin-induced headaches.
    Thornby KA; Henneman A; Brown DA
    Ann Pharmacother; 2015 Jun; 49(6):715-26. PubMed ID: 25757469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of intravenous immune globulin therapy combined with dexamethasone for the initial treatment of acute Kawasaki disease.
    Jibiki T; Terai M; Kurosaki T; Nakajima H; Suzuki K; Inomata H; Terashima I; Honda T; Yasukawa K; Hamada H; Kohno Y
    Eur J Pediatr; 2004 Apr; 163(4-5):229-33. PubMed ID: 14963702
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases: EFNS task force on the use of intravenous immunoglobulin in treatment of neurological diseases.
    Elovaara I; Apostolski S; van Doorn P; Gilhus NE; Hietaharju A; Honkaniemi J; van Schaik IN; Scolding N; Soelberg Sørensen P; Udd B;
    Eur J Neurol; 2008 Sep; 15(9):893-908. PubMed ID: 18796075
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravenous immunoglobulin-associated acute renal failure: case series and literature review.
    Itkin YM; Trujillo TC
    Pharmacotherapy; 2005 Jun; 25(6):886-92. PubMed ID: 15927908
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Guidelines on the use of intravenous immune globulin for neurologic conditions.
    Feasby T; Banwell B; Benstead T; Bril V; Brouwers M; Freedman M; Hahn A; Hume H; Freedman J; Pi D; Wadsworth L
    Transfus Med Rev; 2007 Apr; 21(2 Suppl 1):S57-107. PubMed ID: 17397768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety of intravenous immunoglobulin and plasma exchange in critically ill patients.
    Clark SL; Rabinstein AA
    Neurol Res; 2015 Jul; 37(7):593-8. PubMed ID: 25751423
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does high-dose intravenous immune globulin treatment after bone marrow transplantation increase mortality in veno-occlusive disease of the liver?
    Klaesson S; Ringdén O; Ljungman P; Aschan J; Hägglund H; Winiarski J
    Transplantation; 1995 Dec; 60(11):1225-30. PubMed ID: 8525515
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immediate infusion-related adverse reactions to intravenous immunoglobulin in a prospective cohort of 1765 infusions.
    Bichuetti-Silva DC; Furlan FP; Nobre FA; Pereira CT; Gonçalves TR; Gouveia-Pereira M; Rota R; Tavares L; Mazzucchelli JT; Costa-Carvalho BT
    Int Immunopharmacol; 2014 Dec; 23(2):442-6. PubMed ID: 25257732
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasmapheresis and Intravenous Immune Globulin Improve Neurologic Outcome of Central Pontine Myelinolysis Occurring Post Orthotopic Liver Transplant.
    Ludwig KP; Thiesset HF; Gayowski TJ; Schwartz JJ
    Ann Pharmacother; 2011 Feb; 45(2):e10. PubMed ID: 21304032
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute stroke with high-dose intravenous immune globulin.
    White DA; Leonard MC
    Am J Health Syst Pharm; 2007 Aug; 64(15):1611-4. PubMed ID: 17646563
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravenous immunoglobulin in the treatment of polyarticular juvenile rheumatoid arthritis: a phase I/II study. Pediatric Rheumatology Collaborative Study Group.
    Giannini EH; Lovell DJ; Silverman ED; Sundel RP; Tague BL; Ruperto N
    J Rheumatol; 1996 May; 23(5):919-24. PubMed ID: 8724309
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long term safety of IVIg therapy in multiple sclerosis: 10 years experience.
    Katz U; Kishner I; Magalashvili D; Shoenfeld Y; Achiron A
    Autoimmunity; 2006 Sep; 39(6):513-7. PubMed ID: 17060031
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myocardial infarction during intravenous immunoglobulin infusion in a 65-year-old man with common variable immunodeficiency and subsequent successful repeated administration.
    Davé S; Hagan J
    Ann Allergy Asthma Immunol; 2007 Dec; 99(6):567-70. PubMed ID: 18219840
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adverse effects of intravenous immunoglobulin therapy in 56 patients with autoimmune diseases.
    Sherer Y; Levy Y; Langevitz P; Rauova L; Fabrizzi F; Shoenfeld Y
    Pharmacology; 2001; 62(3):133-7. PubMed ID: 11287813
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A case of deep vein thrombosis and pulmonary thromboembolism after intravenous immunoglobulin therapy.
    Lee YJ; Shin JU; Lee J; Kim K; Kim WS; Ahn JS; Jung CW; Kang WK
    J Korean Med Sci; 2007 Aug; 22(4):758-61. PubMed ID: 17728525
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Not all intravenous immunoglobulin preparations are equally well tolerated.
    Feldmeyer L; Benden C; Haile SR; Boehler A; Speich R; French LE; Hofbauer GF
    Acta Derm Venereol; 2010 Sep; 90(5):494-7. PubMed ID: 20814625
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intravenous gamma globulin as first line therapy in polymyositis and dermatomyositis: an open study in 11 adult patients.
    Cherin P; Piette JC; Wechsler B; Bletry O; Ziza JM; Laraki R; Godeau P; Herson S
    J Rheumatol; 1994 Jun; 21(6):1092-7. PubMed ID: 7932419
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute renal failure and intravenous immune globulin: occurs with sucrose-stabilized, but not with D-sorbitol-stabilized, formulation.
    Chapman SA; Gilkerson KL; Davin TD; Pritzker MR
    Ann Pharmacother; 2004 Dec; 38(12):2059-67. PubMed ID: 15536143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.